COVID-19 has proven to be particularly challenging given the complex pathogenesis of
SARS-CoV-2. Early data have demonstrated how the host response to this novel …

Thrombotic complications of the novel coronavirus (COVID-19) are a concerning aspect of
the disease, due to the high incidence in critically ill patients and poor clinical outcomes …

December 2019 will never be forgotten in the history of medicine when an outbreak of
pneumonia of unknown etiology in Wuhan, China sooner or later prompted the World Health …

Introduction Emerging evidence points to an association between severe clinical
presentation of COVID-19 and increased risk of thromboembolism. One-third of patients …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV‑2), is now a global pandemic. This virus primarily …

There is increasing evidence that novel coronavirus disease 2019 (COVID-19) leads to a
significant coagulopathy, a phenomenon termed “COVID-19 associated coagulopathy.” …

The Covid-19 pandemic has introduced an array of organspecific and systemic phenotypes-
some previously observed in viral infections, including severe acute respiratory syndrome …

Abstract Coronavirus-19 disease (COVID-19), a zoonosis, was first reported in the city of
Wuhan, province of Hubei, China in December 2019. The disease is caused by the Severe …

Abstract The 2019 coronavirus disease (COVID-19) presents with a large variety of clinical
manifestations ranging from asymptomatic carrier state to severe respiratory distress …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to a worldwide
pandemic, and patients with the infection are referred to as having COVID‐19. Although …